Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Promising final phase IIa results presented for IPED-2015 in erectile dysfunction

March 17, 2020

AZD-2373 begins first-in-human trial in healthy male subjects of African ancestry

March 11, 2020

FDA approves Procysbi delayed-release oral granules in packets

Feb. 19, 2020

Allena plans protocol amendment for second pivotal trial of reloxaliase for enteric hyperoxaluria

Feb. 12, 2020

New hydroxyacid oxidase 1 inhibitors discovered at Orfan Biotech

Jan. 28, 2020

LNA-anti-miR-150 ameliorates FSGS in vivo

Jan. 28, 2020

Sanifit opens enrollment in phase III study of SNF-472 for calciphylaxis

Jan. 14, 2020

Scripps Research Institute presents myosin-2 ATPase activity inhibitors

Jan. 8, 2020

Phase II study begins for URO-902 in overactive bladder

Dec. 24, 2019

Phase I study of Metablok achieves primary endpoints

Dec. 19, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...